Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2)

Armando Santoro; Garrido Pilar; Daniel S.W. Tan; Jon Zugazagoitia; Frances A. Shepherd; Alessandra Bearz; Fabrice Barlesi; Tae Min Kim; Tobias R. Overbeck; Enriqueta Felip; Can Cai; Simantini Eddy; Tracey McCulloch; Eric S. Schaefer

doi:10.1186/s12885-024-13210-9

Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2)

Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer

Résultats de recherche: Contribution à un journal › !!Comment/debate

Résumé

Following publication of the original article [1], the authors identified an error in the author name of Simantini Eddy. Their given name and family name were erroneously transposed. The incorrect author name is: Eddy Simantini The correct author name is: Simantini Eddy The author group has been updated above and the original article [1] has been corrected.

langue originale	Anglais
Numéro d'article	1436
journal	BMC Cancer
Volume	24
Numéro de publication	1
Les DOIs	https://doi.org/10.1186/s12885-024-13210-9
état	Publié - 1 déc. 2024

Accès au document

10.1186/s12885-024-13210-9

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Santoro, A., Pilar, G., Tan, D. S. W., Zugazagoitia, J., Shepherd, F. A., Bearz, A., Barlesi, F., Kim, T. M., Overbeck, T. R., Felip, E., Cai, C., Eddy, S., McCulloch, T., & Schaefer, E. S. (2024). Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2). BMC Cancer, 24(1), Article 1436. https://doi.org/10.1186/s12885-024-13210-9

@article{42dba51200424f118dad14e653f2e401,

title = "Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2)",

abstract = "Following publication of the original article [1], the authors identified an error in the author name of Simantini Eddy. Their given name and family name were erroneously transposed. The incorrect author name is: Eddy Simantini The correct author name is: Simantini Eddy The author group has been updated above and the original article [1] has been corrected.",

author = "Armando Santoro and Garrido Pilar and Tan, \{Daniel S.W.\} and Jon Zugazagoitia and Shepherd, \{Frances A.\} and Alessandra Bearz and Fabrice Barlesi and Kim, \{Tae Min\} and Overbeck, \{Tobias R.\} and Enriqueta Felip and Can Cai and Simantini Eddy and Tracey McCulloch and Schaefer, \{Eric S.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

day = "1",

doi = "10.1186/s12885-024-13210-9",

language = "English",

volume = "24",

journal = "BMC Cancer",

issn = "1471-2407",

number = "1",

}

Santoro, A, Pilar, G, Tan, DSW, Zugazagoitia, J, Shepherd, FA, Bearz, A, Barlesi, F, Kim, TM, Overbeck, TR, Felip, E, Cai, C, Eddy, S, McCulloch, T & Schaefer, ES 2024, 'Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2)', BMC Cancer, VOL. 24, Numéro 1, 1436. https://doi.org/10.1186/s12885-024-13210-9

Correction to: Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2). / Santoro, Armando; Pilar, Garrido; Tan, Daniel S.W. et al.
Dans: BMC Cancer, Vol 24, Numéro 1, 1436, 01.12.2024.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Correction to

T2 - Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC (BMC Cancer, (2024), 24, 1, (1307), 10.1186/s12885-024-12841-2)

AU - Santoro, Armando

AU - Pilar, Garrido

AU - Tan, Daniel S.W.

AU - Zugazagoitia, Jon

AU - Shepherd, Frances A.

AU - Bearz, Alessandra

AU - Barlesi, Fabrice

AU - Kim, Tae Min

AU - Overbeck, Tobias R.

AU - Felip, Enriqueta

AU - Cai, Can

AU - Eddy, Simantini

AU - McCulloch, Tracey

AU - Schaefer, Eric S.

PY - 2024/12/1

Y1 - 2024/12/1

N2 - Following publication of the original article [1], the authors identified an error in the author name of Simantini Eddy. Their given name and family name were erroneously transposed. The incorrect author name is: Eddy Simantini The correct author name is: Simantini Eddy The author group has been updated above and the original article [1] has been corrected.

AB - Following publication of the original article [1], the authors identified an error in the author name of Simantini Eddy. Their given name and family name were erroneously transposed. The incorrect author name is: Eddy Simantini The correct author name is: Simantini Eddy The author group has been updated above and the original article [1] has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85209715671&partnerID=8YFLogxK

U2 - 10.1186/s12885-024-13210-9

DO - 10.1186/s12885-024-13210-9

M3 - Comment/debate

AN - SCOPUS:85209715671

SN - 1471-2407

VL - 24

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 1436

ER -